Legislation on pediatric medicines is sowing the seeds for a better future, but we must maintain momentum if children are to get the best possible care.
Helen Sammons |
In 2007, new legislation compelled drugmakers to test new products in pediatric populations – a big step forward for children. Doctors should never again be put in the position of having no information on whether a new medicine is safe or effective for younger patients. Unfortunately, there is a catch. The vast majority of drugs being prescribed for children are not new – they are old drugs often used off label.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.